Loading clinical trials...

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT02555878

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

The purpose of this study is to demonstrate that rivaroxaban is superior to placebo for reducing the risk of the primary composite outcome as defined by objectively confirmed symptomatic lower extremi...

Lead sponsor: Janssen Research & Development, LLC•70 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

NCT07287098 · Breast Neoplasms

RECRUITINGPhase 1

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms

RECRUITINGPhase 1

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

NCT07258836 · Neoplasms, Healthy

RECRUITINGPhase 2

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

NCT07169851 · Nausea, Vomiting, and more

RECRUITINGNA

Impact of SMS Messaging on Participation in Colorectal Cancer Screening

NCT07628998 · Colorectal Neoplasms, Early Detection of Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 12, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment841

Start dateSep 2015

Last updatedSep 12, 2019

Condition

Neoplasms

Locations shown

Phoenix, Arizona

Tucson, Arizona

Little Rock, Arkansas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 12, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions